More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
Market cap
$5.28B
EPS
5.31
P/E ratio
32.9
Price to sales
4.93
Dividend yield
0.577%
Beta
0.851529
Previous close
$168.70
Today's open
$169.52
Day's range
$165.77 - $170.40
52 week range
$147.18 - $183.90
show more
CEO
Theodore L. Harris
Employees
1352
Headquarters
Montvale, NJ
Exchange
Nasdaq Global Select
Shares outstanding
31777324
Issue type
Common Stock
Materials
Chemicals
Balchem Corporation to Participate in Baird's Global Industrial Conference on November 11, 2026
MONTVALE, N.J., Oct. 28, 2026 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC), a global specialty ingredient manufacturer for health and nutrition markets, announced they will participate in Baird's Global Industrial Conference on November 11, 2026.
GlobeNewsWire • Oct 28, 2026

3 Companies With Room to Pass on Costs to Manage Inflation
Despite the Federal Reserve's decision to raise interest rates in September 2026, inflation crept up again that month, with the Consumer Price Index rising 0.6% compared to 0.4% in August. Not all goods—and therefore not all companies—will experience the same impact, and energy and gasoline prices have been among the fastest to rise.
MarketBeat • Oct 26, 2026

Balchem: Record Sales, Great Fundamentals, Priced Fully, Hold
Balchem posted strong sales growth of 8.6% during the quarter and free cash flow of $57.9 million. BCPC's business is great—growing earnings, low borrowings, and continuous share buybacks. My DCF valuation states the stock should be priced at roughly $88. The current price of $177 reflects an overvaluation of roughly 50%.
Seeking Alpha • Oct 24, 2026

Balchem: 3 Key Takeaways for Long-Term Investors
Third-quarter net sales rose 8.6% year over year to $291 million. Human nutrition and health segment sales increased 8.1% to $188 million.
The Motley Fool • Oct 23, 2026

Balchem Corporation (BCPC) Q3 2026 Earnings Call Transcript
Balchem Corporation (BCPC) Q3 2026 Earnings Call Transcript
Seeking Alpha • Oct 23, 2026

Balchem Corporation Reports Third Quarter 2026 Financial Results
MONTVALE, N.J., Oct. 23, 2026 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) today reported financial results for its 2026 fiscal third quarter ended September 30, 2026.
GlobeNewsWire • Oct 23, 2026

Balchem Corporation Announces Quarterly Conference Call for Third Quarter 2026 Financial Results on October 23, 2026
MONTVALE, N.J., Oct. 09, 2026 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) today announced that a conference call will be held on Friday, October 23, 2026, at 11:00 AM Eastern Time (ET) to review third quarter results.
GlobeNewsWire • Oct 9, 2026

Balchem Corporation to Participate in the 9th Annual Wells Fargo Consumer Conference on September 23, 2026
MONTVALE, N.J., Sept. 09, 2026 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC), a global specialty ingredient manufacturer for health and nutrition markets, announced they will participate in the 9th Annual Wells Fargo Consumer Conference on September 23, 2026.
GlobeNewsWire • Sep 9, 2026

Balchem: It's A Buy From Me After Posting Strong Q2 Results
Balchem Corporation posted Q2 results, with EPS of $1.49 beating estimates by $0.07, while surpassing the consensus by $15M and was up 11% YoY. All areas of the business posted impressive results, as the minimum revenue growth for a segment was 8.9%, while the peak was 15% in Animal Nutrition & Health. The stock appears to be trading for a ~9% discount to its fair value right now based on my FCF valuation model.
Seeking Alpha • Aug 2, 2026

Balchem Corporation (BCPC) Q2 2026 Earnings Call Transcript
Balchem Corporation (BCPC) Q2 2026 Earnings Call Transcript
Seeking Alpha • Jul 31, 2026

¹ Disclosures

Open an M1 investment account to buy and sell Balchem Corporation commission-free¹. Build wealth for the long term using automated trading and transfers.